GB0820965A
GB0820965D0
(en)
|
2008-11-17 |
2008-11-17 |
Suppression of cancers
|
CA2727082A
CA2727082C
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in suppression of acromegaly
|
US12/996,643
US20110171191A1
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine diseases
|
CA2726092A
CA2726092A1
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of cancers
|
JP2011513056A
JP5728380B2
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine disease
|
CN200980130069.3A
CN102112145B
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine diseases
|
EP19175007.4A
EP3590956A1
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine diseases
|
EP09762018.1A
EP2310028B1
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in the treatment of acromegaly
|
PCT/GB2009/050666
WO2009150470A2
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of cancers
|
EP18199184.5A
EP3473643A1
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in the treatemnt of cancer
|
EP13179177.4A
EP2719392B1
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in the treatment of acromegaly
|
EP09762019.9A
EP2310029B1
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in the treatment of cancer
|
US12/996,641
US10240138B2
(en)
|
2008-06-12 |
2009-06-11 |
Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
|
CN201710541016.7A
CN107446053A
(en)
|
2008-06-12 |
2009-06-11 |
The suppression of cancer
|
ES09762018.1T
ES2614990T3
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in the treatment of acromegaly
|
BRC10915888A
BRPI0915888E2
(en)
|
2008-06-12 |
2009-06-11 |
polypeptide, its activation method, nucleic acid sequence encoding it and its use
|
PCT/GB2009/050665
WO2009150469A2
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine diseases
|
CN201410295607.7A
CN104328100B
(en)
|
2008-06-12 |
2009-06-11 |
The inhibition of neuroendocrine disease
|
AU2009259033A
AU2009259033B2
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine diseases
|
AU2009259034A
AU2009259034B2
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of cancers
|
ES13179177T
ES2750651T3
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in the treatment of acromegaly
|
KR1020117000258A
KR101731655B1
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of cancers
|
KR1020117000251A
KR101642363B1
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of neuroendocrine diseases
|
CN2009801220928A
CN102083451A
(en)
|
2008-06-12 |
2009-06-11 |
Suppression of cancers
|
ES09762019T
ES2732205T3
(en)
|
2008-06-12 |
2009-06-11 |
Fusion proteins for use in cancer treatment
|
JP2011513057A
JP5799397B2
(en)
|
2008-06-12 |
2009-06-11 |
Cancer suppression
|
BRPI0915142A
BRPI0915142A8
(en)
|
2008-06-12 |
2009-06-11 |
POLYPEPTIDES, NUCLEIC ACID AND USES THEREOF
|
ZA2010/08425A
ZA201008425B
(en)
|
2008-06-12 |
2010-11-24 |
Suppression of cancers
|
ZA2010/08536A
ZA201008536B
(en)
|
2008-06-12 |
2010-11-29 |
Suppression of neuroendocrine diseases
|
IL209854A
IL209854A
(en)
|
2008-06-12 |
2010-12-08 |
Polypeptide, nucleic acid sequence encoding such a polypeptide and the use of such a polypeptide in the preparation of a medicament for suppressing cancer
|
IL209855A
IL209855A
(en)
|
2008-06-12 |
2010-12-08 |
Polypeptide, nucleic acid sequence encoding such a polypeptide and the use of such a polypeptide in the preparation of a medicament for treating acromegaly
|
US12/969,810
US8796216B2
(en)
|
2008-06-12 |
2010-12-16 |
Suppression of neuroendocrine diseases
|
US12/969,826
US20110158973A1
(en)
|
2008-06-12 |
2010-12-16 |
Suppression of cancers
|
US14/250,959
US20140302006A1
(en)
|
2008-06-12 |
2014-04-11 |
Suppression of neuroendocrine diseases
|
US14/250,954
US10550377B2
(en)
|
2008-06-12 |
2014-04-11 |
Suppression of prostate cancer using a targeted clostridial neurotoxin
|
JP2014087047A
JP5891258B2
(en)
|
2008-06-12 |
2014-04-21 |
Suppression of neuroendocrine disease
|
HK18106227.2A
HK1246809A1
(en)
|
2008-06-12 |
2018-05-14 |
Suppression of cancers
|